Home › Diffuse Scleroderma › Maryland › Baltimore
Diffuse Scleroderma clinical trials in Baltimore, MD
5 studies for Diffuse Scleroderma are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- Johns Hopkins Hospital, Baltimore
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
RecruitingPhase 2
- Johns Hopkins University, Baltimore
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
RecruitingPhase 2
- Johns Hopkins, Baltimore
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RecruitingPhase 2/3
- GSK Investigational Site, Baltimore
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- Johns Hopkins University School of Medicine, Baltimore
Diffuse Scleroderma trials in other cities
- New York City, NY7 studies
- Durham, NC6 studies
- Los Angeles, CA6 studies
- Ann Arbor, MI6 studies
- Boston, MA5 studies
- Chicago, IL5 studies
- Kansas City, KS4 studies
- Philadelphia, PA4 studies
- Pittsburgh, PA4 studies
- Charleston, SC3 studies
- Houston, TX3 studies
- New Orleans, LA3 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Prostate Cancer45 studies
- Breast Cancer44 studies
- Lung Cancer41 studies
- Cancer (all types)36 studies
- Colorectal Cancer30 studies
- Pancreatic Cancer30 studies
- Metastatic Cancer26 studies
- Obesity24 studies
- Bladder Cancer24 studies
- Ovarian Cancer23 studies
- Heart Failure23 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.